Flucytosine Capsules
» Flucytosine Capsules contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of flucytosine (C4H4FN3O).
Packaging and storage— Preserve in tight, light-resistant containers.
Identification—
A: The UV absorption spectrum of the solution from the Capsule contents obtained in the Assay exhibits maximum absorption at the same wavelength as that of the Standard solution, and the two spectra are similar between 260 nm and 350 nm.
B: Shake a portion of the contents of Capsules, equivalent to about 500 mg of flucytosine, with 10 mL of water. Filter, and to 2 mL of the filtrate add 1 mL of sodium pentacyanoaminoferrate reagent [prepared by dissolving 100 mg of sodium (tri)pentacyanoaminoferrate in 20 mL of sodium carbonate solution (1 in 100)] and 1 mL of 3 percent hydrogen peroxide: on standing, a darker green is produced than that produced by a blank.
Dissolution 711
Medium: water; 900 mL.
Apparatus 2: 75 rpm.
Time: 60 minutes.
Procedure— Determine the amount of C4H4FN3O dissolved by employing UV absorption at the wavelength of maximum absorbance at about 276 nm on filtered portions of the solution under test, suitably diluted with Dissolution Medium, if necessary, in comparison with a Standard solution having a known concentration of USP Flucytosine RS in the same Medium.
Tolerances— Not less than 80% (Q) of the labeled amount of C4H4FN3O is dissolved in 60 minutes.
Uniformity of dosage units 905: meet the requirements.
Assay— Weigh the contents of not fewer than 20 Capsules, and determine the average weight per Capsule. Mix the combined contents, and transfer an accurately weighed portion of the powder, equivalent to about 250 mg of flucytosine, to a 250-mL volumetric flask. Add about 50 mL of 0.1 N hydrochloric acid, shake by mechanical means for 30 minutes, then add 0.1 N hydrochloric acid to volume, mix, and filter, discarding the first 20 mL of the filtrate. Dilute 10 mL of the clear filtrate with 0.1 N hydrochloric acid to 250 mL. Dilute 10.0 mL of this solution with 0.1 N hydrochloric acid to 50 mL. Dissolve an accurately weighed quantity of USP Flucytosine RS in 0.1 N hydrochloric acid, and dilute quantitatively and stepwise with the same solvent to obtain a Standard solution having a known concentration of about 8 µg per mL. Concomitantly determine the absorbances of both solutions in 1-cm cells at the wavelength of maximum absorbance at about 285 nm, with a suitable spectrophotometer, using 0.1 N hydrochloric acid as the blank. Calculate the quantity, in mg, of flucytosine (C4H4FN3O) in the portion of Capsule contents taken by the formula:
31.25C(AU / AS)
in which C is the concentration, in µg per mL, of USP Flucytosine RS in the Standard solution; and AU and AS are the absorbances of the solution from the Capsule contents and the Standard solution, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Behnam Davani, Ph.D., M.B.A.
Senior Scientist
1-301-816-8394
(MDAA05) Monograph Development-Antivirals and Antimicrobials
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientist
1-301-816-8106
(BPC05) Biopharmaceutics05
USP32–NF27 Page 2385
Pharmacopeial Forum: Volume No. 29(1) Page 68